Luca Issi, Senior Biotechnology Research Analyst at RBC Capital Markets, discusses the art of building biopharma breakthroughs with Arjun Goyal, Co-Founder and Managing Director of Vida Ventures.

Key Points

• Maturation of the industry is increasing innovation and capital inflows
• Strong science, management and investors can keep the IPO window open